EP Patent

EP1214059A2 — Surface modified particulate compositions of biologically active substances

Assigned to Skyepharma Canada Inc · Expires 2002-06-19 · 24y expired

What this patent protects

This invention disclosure relates to compositions for the delivery of stable surface modified sub-micron and micron sized particles of water-insoluble biologically active substances from a non-aqueous medium that self-disperses on exposure to an aqueous environment.

USPTO Abstract

This invention disclosure relates to compositions for the delivery of stable surface modified sub-micron and micron sized particles of water-insoluble biologically active substances from a non-aqueous medium that self-disperses on exposure to an aqueous environment.

Drugs covered by this patent

Patent Metadata

Patent number
EP1214059A2
Jurisdiction
EP
Classification
—
Expires
2002-06-19
Drug substance claim
No
Drug product claim
No
Assignee
Skyepharma Canada Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.